Scientific analysis of the data found no evidence that the incidence of venous thromboembolism in some vaccinated patients was due to exposure to the AstraZeneca vaccine, European Medicines Agency (EMA) noted, adding that it considers it possible to continue mass vaccination with this drug.
According to Medportal.ru, the regulator’s statement noted that the incidence of thrombosis is less than one person per million vaccinated in the UK – no more than in the unvaccinated population. According to experts, the thrombosis in these patients could have been caused by other causes.
The medical regulator has advised people not to give up getting vaccinated because the benefits of getting vaccinated outweigh the risks of potential side effects.
A group of Norwegian scientists have confirmed the risk of a dangerous side effect caused by the coronavirus vaccine developed by AstraZeneca.
Several EU countries have temporarily suspended vaccination with the British-Swedish company AstraZeneca due to a series of reports of possible thromboembolic complications in those vaccinated.